Latest Articles

Publication Date
All News Scientific
Victoria’s Secret Spotlight: Dylan Sprouse and Barbara Palvin Champion Women’s Health and Precancer Diseases Awareness - Oncodaily

Victoria’s Secret Spotlight: Dylan Sprouse and Barbara Palvin Champion Women’s Health and Precancer Diseases Awareness Oncodaily

Published: Oct. 18, 2025, 9:25 p.m.
Read Full Article
Minister ‘sorry’ for endometriosis treatment waits as she launches new framework - Ireland Live

Minister ‘sorry’ for endometriosis treatment waits as she launches new framework Ireland Live

Published: Oct. 18, 2025, 7:27 p.m.
Read Full Article
Minister ‘sorry’ for endometriosis treatment waits as she launches new framework - westernpeople.ie

Minister ‘sorry’ for endometriosis treatment waits as she launches new framework westernpeople.ie

Published: Oct. 18, 2025, 6:10 p.m.
Read Full Article
Minister ‘sorry’ for endometriosis treatment waits as she launches new framework - BreakingNews.ie

Minister ‘sorry’ for endometriosis treatment waits as she launches new framework BreakingNews.ie

Published: Oct. 18, 2025, 5:29 p.m.
Read Full Article
Minister ‘sorry’ for endometriosis treatment waits as she launches new framework - The Journal

Minister ‘sorry’ for endometriosis treatment waits as she launches new framework The Journal

Published: Oct. 18, 2025, 4:34 p.m.
Read Full Article
Minister ‘sorry’ for endometriosis treatment waits as she launches new framework - Nenagh Live

Minister ‘sorry’ for endometriosis treatment waits as she launches new framework Nenagh Live

Published: Oct. 18, 2025, 4:18 p.m.
Read Full Article
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen - The AI Journal

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen The AI Journal

Published: Oct. 18, 2025, 10:28 a.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - The AI Journal

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer The AI Journal

Published: Oct. 18, 2025, 10:20 a.m.
Read Full Article
The female scientists who finally found an answer to endometriosis wait times - The i Paper

The female scientists who finally found an answer to endometriosis wait times The i Paper

Published: Oct. 18, 2025, 5 a.m.
Read Full Article
Endometriosis diagnosis wait cut from years to just weeks in major breakthrough - MSN

Endometriosis diagnosis wait cut from years to just weeks in major breakthrough MSN

Published: Oct. 17, 2025, 10:05 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!